A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells.

Kleijn, A; Kloezeman, J J; Balvers, R K; van der Kaaij, M; Dirven, C M F; Leenstra, S; Lamfers, M L M

Kleijn, A; Kloezeman, J J; Balvers, R K; van der Kaaij, M; Dirven, C M F; Leenstra, S; Lamfers, M L M.

Afiliação

Kleijn A; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands.
Kloezeman JJ; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands.
Balvers RK; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands.
van der Kaaij M; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands.
Dirven CM; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands.
Leenstra S; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands; Department of Neurosurgery, St. Elisabeth Hospital, 5022 GC Tilburg, Netherlands.
Lamfers ML; Department of Neurosurgery, Brain Tumor Center, Erasmus MC, 3015 CE Rotterdam, Netherlands.

Stem Cells Int ; 2016: 5623235, 2016.

Article em En | MEDLINE | ID: mdl-27274737

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google